Webinar: High-throughput and automation in novel modalities (msAbs, ADCs, AOCs) screening, characterization, and beyond

Novel biotherapeutics, including bispecific and multispecific antibodies (bsAb, msAb), antibody-drug conjugates (ADCs), are revolutionizing biomedical therapies yet pose analytical challenges due to their sequence diversity, structural complexity, and susceptibility to various degradation pathways. 

In this presentation, Ben Niu will showcase how his team has integrated advanced techniques such as automation and machine learning to achieve unprecedented mass spectrometry-focused sample handling capabilities and rapid turnover rates. These approaches deliver unmatched depth and breadth in understanding diverse molecular modalities within a condensed timeline. 

 

Speakers

Ben Niu

 

Principal Scientist, Discovery Biotherapeutics

Bristol Myers Squibb 

Ben Niu is a Principal Scientist at Bristol Myers Squibb (BMS), leading a pioneering mass spectrometry team within the Discovery Biotherapeutics department. With over seven years of experience in the biopharmaceutical industry, Ben specializes in analytical characterization, particularly in mass spectrometry techniques, driving critical insights for drug development. He champions the integration of automation and machine learning to revolutionize analytical workflows.

Xiaoxi Zhang

 

Application Manager, Pharma & biopharma

Thermo Fisher Scientific

Xiaoxi Joined Thermo Fisher Scientific China in 2012. Currently she is Application Manager in Pharma and Biopharma vertical marketing team, Chromatography and Mass Spectrometry Division, Thermo Fisher Scientific. Xiaoxi is managing collaborations with China regulatory authority, biopharma KOLs. She has 10+ publications/orals/posters in biotherapeutic characterization since 2021.

 

Register for on-demand webinar now!


To ensure that we are complying with your preferences, we need to confirm your permission to send you communication. Please check the form of communication that you agree for us to contact you:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.